News
Our newsfeed is undergoing a system update. All stories will be repopulated soon!
-
FDA Approves Epcoritamab with Rituximab and Lenalidomide for R/R FL
On November 18, 2025, the US Food and Drug Administration approved epcoritamab-bysp…
-
Ziftomenib Approved for NPM1-Mutant R/R AML
On November 13, 2025, the US Food and Drug Administration approved the…
-
New Interchangeable Pertuzumab Biosimilar Approved for HER2-Positive Breast Cancer
On November 13, 2025, the US Food and Drug Administration approved pertuzumab-dpzb…
Newsletter Coming Soon!
Beginning in 2026, we will be sending out a quarterly newsletter on key oncology insights and updates.